Short bowel syndrome (SBS) is an intestinal disorder characterized by reduced length of the gut most due to intestinal resection, resulting in malabsorption, malnutrition, and water and electrolyte disturbances. Intestinal adaptation is a long-term process in which GIT hormones, growth peptides, cytokines etc. are involved. These mechanisms have not been fully clarified yet. The most important seem to be GLP-2 and other gut hormones. The aim of our study was to consider the changes of the levels of selected gut hormones and parameters of glucose homeostasis during the mixed liquid meal test in one year of follow up after the gut resection. Seventeen patients with SBS type I were included into our study. The meal test and measuring of selected parameters (GLP-2, GLP-1, ghrelin, insulin, glucagon, GIP, amylin) were conducted after 2 weeks, 6 and 12 months from its initiation, respectively. During one year of this study patients´ nutritional status improved due to sufficient parenteral nutrition, despite no change in body weight. Hormones possibly involved in intestinal adaptation (GLP-2, GLP-1, ghrelin) did not differ in meal test, neither levels nor AUC. Only higher insulin and glucose levels after one year of follow-up may indicate the beginning of intestinal adaptation process and improving intestinal functions. We conclude that impaired GLP-2 secretion is probably the main reason for the limited adaptation ability in patients with SBS type I.

3rd Department of Internal Medicine Department of endocrinology and metabolism General University Hospital Prague 1st Faculty of Medicine Charles University Prague Czech Republic

Zobrazit více v PubMed

Dekaney CM, Fong JJ, Rigby RJ, Lund PK, Henning SJ, Helmrath MA. Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in mice. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1013–G1022. doi: 10.1152/ajpgi.00218.2007. PubMed DOI

Le Beyec J, Billiauws L, Bado A, Joly F, Le Gall M. Short Bowel Syndrome: A paradigm for intestinal adaptation to nutrition? Annu Rev Nutr. 2020;40:299–321. doi: 10.1146/annurev-nutr-011720-122203. PubMed DOI

O’Connor TP, Lam MM, Diamond J. Magnitude of functional adaptation after intestinal resection. Am J Physiol. 1999;276:R1265–R1275. doi: 10.1152/ajpregu.1999.276.5.R1265. PubMed DOI

Rubin DC, Levin MS. Mechanisms of intestinal adaptation. Best Pract Res Clin Gastroenterol. 2016;30(2):237–248. doi: 10.1016/j.bpg.2016.03.007. PubMed DOI PMC

Gillard L, Billiauws L, Stan-Iuga B, et al. Enhanced ghrelin levels and hypothalamic orexigenic AgRP and NPY neuropeptide expression in models of jejuno-colonic short bowel syndrome. Sci Rep. 2016;6:28345. doi: 10.1038/srep28345. PubMed DOI PMC

Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. Bile acids and the gut microbiome. Curr Opin Gastroenterol. 2014;30:332–338. doi: 10.1097/MOG.0000000000000057. PubMed DOI PMC

Drucker DJ, Erlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A. 1996;93:7911–6. doi: 10.1073/pnas.93.15.7911. PubMed DOI PMC

Drucker DJ. Gut adaptation and the glucagon-like peptides. Gut. 2002;50:428–435. doi: 10.1136/gut.50.3.428. PubMed DOI PMC

Jeppesen PB, Hartmann B, Holst JJ. Gut hormones in short bowel syndrome with intestinal failure. Peptides. 2000;21:1077–1085.

Hsieh J, Longuet C, Maida A, Bahrami J, Xu E, Baker CL, Brubaker PL, et al. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology. 2009;137:997–1005. 1005.e1–4. doi: 10.1053/j.gastro.2009.05.051. PubMed DOI

Maljaars PWJ, Peters HPF, Mela DJ, Masclee A. Ileal brake: a sensible food target for appetite control. A review. Physiol Behav. 2008;95:271–281. doi: 10.1016/j.physbeh.2008.07.018. PubMed DOI

Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87:1409–1439. doi: 10.1152/physrev.00034.2006. PubMed DOI

Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD. Amylin: pharmacology, physiology, and clinical potential. Pharmacol Rev. 2015;67:564–600. doi: 10.1124/pr.115.010629. PubMed DOI

Dehestani B, Stratford NR, le Roux CW. Amylin as a future obesity treatment. J Obes Metab Syndr. 2021;30:320–325. doi: 10.7570/jomes21071. PubMed DOI PMC

Onishi S, Kaji T, Yamada W, Nakame K, Machigashira S, Kawano M, Yano K, et al. Ghrelin stimulates intestinal adaptation following massive small bowel resection in parenterally fed rats. Peptides. 2018;106:59–67. doi: 10.1016/j.peptides.2018.06.009. PubMed DOI

Ibrahim Abdalla MM. Ghrelin - Physiological Functions and Regulation. Eur Endocrinol. 2015 Aug;11(2):90–95. doi: 10.17925/EE.2015.11.02.90. PubMed DOI PMC

Jiao ZT, Luo Q. Molecular mechanisms and health benefits of ghrelin: a narrative review. Nutrients. 2022;14:4191. doi: 10.3390/nu14194191. PubMed DOI PMC

Schoeler M, Klag T, Wendler J, Bernhard S, Adolph M, Kirschniak A, Goetz M, et al. GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting. Therap Adv Gastroenterol. 2018;11:1756284818793343. doi: 10.1177/1756284818793343. DOI

Little TJ, Doran S, Meyer JH, Smout AJ, O’Donovan DG, Wu KL, Jones KL, et al. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab. 2006;291:E647–E655. doi: 10.1152/ajpendo.00099.2006. PubMed DOI

Madsen KB, Askov-Hansen C, Naimi RM, Brandt CF, Hartmann B, Holst JJ, Mortensen PB, et al. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study. Regul Pept. 2013;184:30–39. doi: 10.1016/j.regpep.2013.03.025. PubMed DOI

Lai SW, de Heuvel E, Wallace LE, Hartmann B, Holst JJ, Brindle ME, Chelikani PK, et al. Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats. PLoS One. 2017;12:e0181453. doi: 10.1371/journal.pone.0181453. PubMed DOI PMC

Muto M, Kaji T, Mukai M, Nakame K, Yoshioka T, Tanimoto A, Matsufuji H. Ghrelin and glucagon-like peptide-2 increase immediately following massive small bowel resection. Peptides. 2013;43:160–166. doi: 10.1016/j.peptides.2013.03.006. PubMed DOI

Glerup P, Sonne K, Berner-Hansen M, Skarbaliene J. Short- versus long-term, gender and species differences in the intestinotrophic effects of long-acting glucagon-like peptide 2 analog. Physiol Res. 2022;71:323–326. doi: 10.33549/physiolres.934839. PubMed DOI PMC

Jeppesen PB, Vanuytsel T, Subramanian S, Joly F, Wanten G, Lamprecht G, Kunecki M, et al. Glepaglutide, a long-acting glucagon-like peptide-2 analogue, reduces parenteral support in patients with short bowel syndrome: a phase 3 randomized controlled trial. Gastroenterology. 2025;168:701–713.e6. doi: 10.1053/j.gastro.2024.11.023. PubMed DOI

Jeppesen PB. Growth factors in short-bowel syndrome patients. Gastroenterol Clin North Am. 2007;36:109–121. vii. doi: 10.1016/j.gtc.2007.01.007. PubMed DOI

Naberhuis JK, Deutsch AS, Tappenden KA. Teduglutide-stimulated intestinal adaptation is complemented and synergistically enhanced by partial enteral nutrition in a neonatal piglet model of short bowel syndrome. JPEN J Parenter Enteral Nutr. 2017;41:853–865. doi: 10.1177/0148607115602891. PubMed DOI

Al-Sabah S, Alasfar F, Al-Khaledi G, Dinesh R, Al-Saleh M, Abul H. Incretin response to a standard test meal in a rat model of sleeve gastrectomy with diet-induced obesity. Obes Surg. 2014;24:95–101. doi: 10.1007/s11695-013-1056-2. PubMed DOI

Tappenden KA. Anatomical and physiological considerations in short bowel syndrome: Emphasis on intestinal adaptation and the role of enterohormones. Nutr Clin Pract. 2023;38(Suppl 1):S27–S34. doi: 10.1002/ncp.10991. PubMed DOI

Jeppesen PB, Hartmann B, Hansen BS, Thulesen J, Holst JJ, Mortensen PB. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut. 1999;45:559–563. doi: 10.1136/gut.45.4.559. PubMed DOI PMC

Fourati S, de Dreuille B, Bettolo J, Hutinet C, Le Gall M, Bado A, Joly F, et al. Hyperphagia is prominent in adult patients with short bowel syndrome: A role for the colon? Clin Nutr. 2023;42:2109–2115. doi: 10.1016/j.clnu.2023.09.003. PubMed DOI

Fjermestad H, Hvistendahl M, Jeppesen PB. Fasting and postprandial plasma citrulline and the correlation to intestinal function evaluated by 72-hour metabolic balance studies in short bowel jejunostomy patients with intestinal failure. JPEN J Parenter Enteral Nutr. 2018;42:418–426. doi: 10.1177/0148607116687497. PubMed DOI

Zhang X, Young RL, Bound M, Hu S, Jones KL, Horowitz M, Rayner CK, et al. Comparative effects of proximal and distal small intestinal glucose exposure on glycemia, incretin hormone secretion, and the incretin effect in health and type 2 diabetes. Diabetes Care. 2019;42:520–528. doi: 10.2337/dc18-2156. PubMed DOI